2022 Archives

Researchers Study CRISPR Gene Editing to Cure HIV

POZ Magazine | December 28, 2022

Tel Aviv University researchers demonstrate success of potential one-time vaccine to treat HIV/AIDS 

ET HealthWorld | December 16, 2022

Progress toward an eventual HIV vaccine

NIH | December 13, 2022

Multi-stage HIV vaccine regimen shows promising results in Phase 1 clinical trial 

News Medical | December 8, 2022

Researchers reveal new insights into novel HIV vaccine strategy

ET HealthWorld | December 5, 2022

Researchers provide new insights into the vexing process that makes HIV stealthy 

News Medical | November 14, 2022

Do broadly neutralising antibodies really have a future in treating HIV?

Aidsmap | November 11, 2022

A Step Toward Eliminating Reservoir Cells?

amfAR, The Foundation for AIDS Research | November 9, 2022

Researchers at Duke School of Medicine receive $25.9 million grant for HIV vaccine research

Duke Chronicle | November 7, 2022

IDWeek 2022 — Meeting Report

NEJM Journal Watch | November 4, 2022

Potential Cure for HIV from CRISPR Gene Editing in Phase 1/2 Clinical Trial 

Contagion Live | October 16, 2022

Gut Microbes Could Play Role in HIV Infection

USNews.com | October 4, 2022

Study reveals new strategy to create an effective HIV vaccine

Mint | October 4, 2022

HIV Vaccine Shows Promise After Decades of Research

AARP | October 4, 2022

Enhanced neutralization potency of an identical HIV neutralizing antibody expressed as different isotypes is achieved through genetically distinct mechanisms

Nature | October 1, 2022

Gut microbiome could contribute to a person's risk for HIV infection, research suggests 

News Medical | September 30, 2022

Merck to Initiate New Phase 3 Clinical Program with Lower Dose of Daily Oral Islatravir in Combination with Doravirine for Treatment of People with HIV-1 Infection

Merck | September 20, 2022 6:45 am ET

License to Kill: Latency HIV-CRISPR pinpoints how to blow latent HIV's cover

Fred Hutch | September 19, 2022

Duke researchers find possible HIV vaccine component

WRAL TechWire | September 17, 2022

Excision's CRISPR gene editing therapy for HIV is heading into human testing after FDA clearance 

Fierce Biotech | September 17, 2022

Strategies for HIV-1 vaccines that induce broadly neutralizing antibodies

Nature | August 12, 2022

Moderna, Excision each enter HIV battle with mRNA and CRISPR tech

Fierce Biotech

Single-cell studies offer new view of how HIV infections persist—and might be cured 

Science | August 3, 2022

Novel HIV combination therapies could prevent viral escape and rebound

University of Washington | July 22, 2022

Combinations of broadly neutralizing antibodies may be a more effective approach to treat HIV 

News-Medical | July 20, 2022

Medical breakthrough! Drug developed by gene editing could cure HIV-AIDS

DNA India | July 13, 2022

HIV breakthrough: Single injection treatment 'defeats virus' during study in world first 

Daily Express | July 3, 2022

Promising Stem Cell Therapy in the Management of HIV & AIDS: A Narrative Review

Dove Medical Press | July 2, 2022

How Far Away Is a Cure for HIV?

TheBody | June 30, 2022

Ascletis Embarks on Mid-stage Study of Potentially Functional Cure for HIV

BioSpace | June 28, 2022


UB program secures $12.8 million to improve the quality of global HIV research 

News-Medical | June 16, 2022

Are we on our way to a one-time treatment for HIV?

Drug Target Review | June 15, 2022

HIV can be treated: Vaccine developed by gene editing could cure AIDS

India Today | June 15, 2022

What's in a name: using person-centred language in HIV research

Aidsmap | June 13, 2022

HIV drug may be a potential treatment for dementia: Study

IndiaTV News | May 31, 2022

Trial to Evaluate Anti-Cytomegalovirus Drug in Treating Inflammation in Patients With HIV 

Pharmacy Times | April 25, 2022

Miller School, CUNY Collaborate on $3.9 Million Study on HIV Risk and Meth Use in Gay Men 

InventUM | University of Miami Miller School of Medicine | April 25, 2022

Methamphetamine Enhances Cryptococcus neoformans Melanization, Antifungal Resistance, and Pathogenesis in a Murine Model of Drug Administration and Systemic Infection

Infect Immun 2022 Apr 21;90(4):e0009122. doi: 10.1128/iai.00091-22.

CRISPR and HIV: New Technique in Human Blood Unveils Potential Paths Toward Cure 

Feinberg News Center - Northwestern University | April 12, 2022

HIV cure research: Trying to eliminate a virus that 'hides out'

Healio | April 12, 2022

HIV remissions involving stem cells forward 'path toward finding a cure'

WTOP | April 6, 2022

CRISPR Technique Identifies New Genes Affecting HIV Infection

Contagion Live | April 4, 2022

The hunt for an AIDS vaccine approaches 40 with hope and caution

AAMC | March 31, 2022

Moderna hits the gas as it begins dosing of 2nd HIV vaccine

Fierce Biotech | March 14, 2022

mRNA Technology Leads to Advances in HIV Vaccine Candidate

Drug Topics | March 2, 2022

Moderna Launches Clinical Trials for HIV Vaccine

WebMD | January 28, 2022

Stem-cell treatment may have cured woman of HIV

Medical News Today | February 22, 2022

What's the impact of the new HIV variant on the HIV response?

UNAIDS | February 22, 2022

Prevalence and outcome of HIV infected children admitted in a tertiary hospital in Northern Tanzania 

BMC Pediatr. 2022 Feb 21;22(1):101. doi: 10.1186/s12887-022-03105-8.

First woman reported cured of HIV after stem cell transplant

Arab News | February 16, 2022

Oral Fungal Infections: Past, Present, and Future 

Front Oral Health. 2022 Feb 3;3:838639. doi: 10.3389/froh.2022.838639. eCollection 2022.

Deep dive into HIV's hidden DNA finds that some people could eventually drop their drugs

aidsmap | January 24, 2022

Understanding Where HIV Hides Offers Clues for a Cure

POZ Magazine | January 17, 2022

“Kick and Kill” Strategy Eliminates HIV Cells in 40% of Mice

Contagion Live | January 12, 2022

Neuropilin-1, a myeloid cell-specific protein, is an inhibitor of HIV-1 infectivity

PNAS | January 11, 2022

Experimental mRNA HIV vaccine shows promise in animals

National Institutes of Health (NIH) | January 11, 2022

Assessment of Oral Health and Prevalence of oral Conditions in Human Immunodeficiency Virus-infected Subjects Visiting Antiretroviral Therapy Centers 

J Pharm Bioallied Sci. (Suppl 2):S1470-S1473. doi: 10.4103/jpbs.jpbs_256_21.

Latency reversal plus natural killer cells diminish HIV reservoir in vivo

Nature Communications | January 10, 2022

Institute Releases Strategic Plan, New Vision, Mission

NIH | January 2022